Total IgE levels in patients with hematologic malignancies.

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• The immune system plays a critical role in cancer progression and suppression.
• Conflicting research exists on the relationship between hematologic malignancies, allergies, and immunoglobulin E (IgE) levels.

Purpose of the Study:

• To compare total IgE levels in patients diagnosed with hematologic malignancies against non-cancer controls.

Main Methods:

• A cross-sectional study conducted in 2023 involving 60 patients with hematological malignancies and 90 non-cancer controls.
• Total IgE levels were measured using the ELISA method.
• Demographic data and IgE levels were analyzed using SPSS 20.

Main Results:

• The median IgE level in patients with hematologic malignancies (7.08) was significantly lower than in the control group (42.41).
• Low total IgE was associated with a 6.79-fold increased odds of hematological malignancy (95% CI: 2.90-15.92).
• After adjusting for age and sex, the adjusted odds ratio for low IgE increased to 15.89 (95% CI: 4.14-60.95).

Conclusions:

• Individuals with hematological cancers exhibit significantly lower total IgE levels when compared to cancer-free individuals.
• This study highlights a potential inverse correlation between total IgE levels and the presence of hematologic malignancies.